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809-5 Poor Outcome in Subsets of Renal Failure Patients 
Undergoing Coronary Artery Bypass Surgery: Mortality 
Results From a Cohort of 4,069 Patients
Saida Zen Campwala, Ramdas G. Pai, Loma Linda University Medical Center, Loma 
Linda, CA
Background: Renal failure increases mortality in CABG patients. We studied the effect on
mortality of renal failure (creatine>2mg/dl) - both non-dialysis dependent (NDDRF) and
dialysis dependent (DDRF) - in high risk subsets of CABG patients.
Methods: This is a retrospective cohort study of 4069 consecutive adult patients who had
CABG from 1993 to 2002. The mortality data was obtained from the National Death
Index.
Results: The patient characteristics: age 67+12 years, men 73% and LV ejection fraction
(EF) 49+16%. Over 3.9 years, 899 (22%) patients died. There were 3796 patients with
normal renal function, and 273 (7%) with renal failure: 201 (5%) NDDRF and 72 (2%)
DDRF. Patients with renal failure had a 5-year mortality of 56%, compared to 22% in
patients with normal renal function (p<0.0001), with 50% in NDDRF, and 70% in DDRF.
When corrected for the differences in the populations, both NDDRF and DDRF were
independent predictors of mortality. In subset analysis, the 5 year mortalities in NDDRF
and DDRF patients were even higher in patients with LVEF <40% (59 and 74%)}, age
>65 years (60 and 70%) and redo-CABG status (64 and 100%). Besides renal dysfunc-
tion, LV dysfunction, advanced age and redo-CABG status were independent predictors
of mortality.
Conclusions: 1) CABG patients with renal failure have a >50% mortality at 5-years,
being higher in DDRF patients 2) In renal failure patients, LV dysfunction, advanced age,
and redo-CABG status increase the 5 year mortality to prohibitive levels.
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1078-89 Stem Cell Mobilization With Granulocyte Macrophage-
Colony Stimulating Factor Has No Effect on Infarct Size 
and Left Ventricular Function in an Experimental Model 
of Acute Myocardial Infarction
John Terrovitis, Apostolos Papalois, Christos Charitos, Paraskevi Dolou, Aggeliki 
Eleftheriou, Efstratios Charitos, Michail Mponios, Panagiotis Glentis, John Nanas, 
University of Athens School of Medicine, Athens, Greece
Background: Stem-cell therapy appears a promising treatment for cardiac repair in
experimental and small-scale clinical studies in the setting of acute myocardial infarction
(AMI). However, bone-marrow aspiration and in-vitro expansion of the desired cell lines
are time-consuming techniques, impractical for implementation during an acute event. e
sought to evaluate the effect of bone-marrow pluripotent stem-cell mobilization with GM-
CSF on infarct size and left ventricular function in AMI, with a protocol easily applicable in
everyday clinical practice. Methods. Ten pigs weighing 30 ± 5 kg were subjected to left
thoracotomy and occlusion of the left anterior descending coronary artery for 1 hour, fol-
lowed by reperfusion. At 50 minutes of ischemia, the animals were randomized to pla-
cebo (Group A, n=5) or GM-CSF (Group B, n=5). Subsequently, the thoracotomy was
closed and the animals recovered. In Group B, 20 µg/kg GM-CSF (molgrastim) was
administered subcutaneously, daily, for 15 days. All animals underwent echocardio-
graphic evaluation at 5 and 28 days after AMI. At 30 days, they underwent a new thorac-
otomy and determination of the infarct size as a percentage of the whole left ventricular
area (with the use of tetrazolium chloride). Results. No difference was observed
between the two Groups in infarct size (7.8 ± 6.1 % vs 7.5 ± 7.7 %, p= 0.951, for Groups
A and B, respectively). There was also no difference in shortening fraction (short axis
view at the mid-papillary level, 34 ± 0.6 % vs 35 ± 0.5 %, p= 0.907), left ventricular end
diastolic diameter (32 ± 0.2 mm vs 34 ± 0.3 mm, p= 0.361), left ventricular end systolic
diameter (21 ± 0.2 % vs 22 ± 0.4 mm, p= 0.584) and systolic thickness of the infarcted
left ventricular wall (0.97 ± 0.2 mm vs 0.98 ± 0.2 mm, p= 0.972), in Groups A and B,
respectively at 28 days of follow-up. Conclusion. Subcutaneous administration of GM-
CSF in the acute phase of acute MI and early post-infarction period does not result in
either a decrease in infarct size or an improvement in LV function. Other protocols for
adequate stem-cell mobilization and concentration in the injured area should be deter-
mined in order to combine efficacy and clinical applicability.
1078-90 Epidermal-Derived Progenitor Cells Engraft the 
Infarcted Myocardium and Express Cardiomyocyte 
Markers
Satyavardhan Pulukurthy, Ryan P. Dunlay, Timothy E. Lindley, Sarah J. Bonner, 
Christopher C. Oberley, Ram V. Sharma, Martine Dunnwald, Robin L. Davisson, 
University of Iowa, Iowa City, IA
Background: Lack of efficient regenerative capacity of the post-infarcted adult heart has
prompted an intensive search for alternative sources of cells capable of repopulating the
injured myocardium.In this study, we tested the hypothesis that skin-derived epidermal
progenitor cells (EPCs) can engraft and express cardiomyocyte markers when trans-
planted into areas of myocardial infarction (MI).
Methods: EPCs were isolated from the epidermis of green fluorescent protein (GFP+)
transgenic C57 mice. Host non-transgenic C57 mice were given MI via open-chest left
anterior descending coronary artery ligation. At the time of MI, GFP+ EPCs or saline
were injected at 2 sites near the infarct zone. Mice were sacrificed at 1, 3 and 6 weeks
and immunofluorescence was performed on heart sections to detect GFP, cardiac, and
epidermal cell markers.
Results: As early as 1 week post-injection, GFP+ cells were engrafted in the infarcted
region of EPC-injected hearts and co-expressed markers for differentiated cardiomyo-
cytes (MHC, α-actinin). Over 6 weeks, GFP+ cells gradually took on morphological fea-
tures of adult myocytes including striated myofibrils (figure below). This was
accompanied by a loss of the epidermal marker keratin 14.
Conclusion: Epidermal-derived progenitor cells engraft the infarcted myocardium to
repopulate lost cardiomyocytes. The abundance, accessibility, and autologous nature of
the skin may provide an exciting new therapeutic strategy for MI.
1078-91 Transdifferentiation of Mesenchymal Stem Cells Into 
Cardiomyocytes by Direct Cell-to-Cell Contact With 
Nenatal Cardiomyocytes but Not Adult Cardiomyocytes
Jihyun Yoon, Seung-Cheol Choi, Do-Sun Lim, Korea University Medical College, Seoul, 
South Korea
Background: Recent studies have demonstrated that direct cell-to-cell interaction is one
of microenvironment factors for transdifferentiation of adult stem cells into cardiomyo-
cytes. We investigated whether transdifferentiation of MSCs into cardiomyocytes was
dependent on developmental stages of cardiomyocytes cocultured, and direct cell-to-cell
interaction was essential for transdifferentiation. Methods and Results: MSCs were iso-
lated from adult rat and cocultured in four different ways; 1) with neonatal cardiomyo-
cytes, 2) with adult cardiomyocytes, 3) with neonatal cardiomyocytes on the cell culture
inserts (double chamber system), 4) with the conditioned medium from neonatal cardi-
omyocytes. After 5 days of coculture with neonatal cardiomyocytes, 9.40±1.15% of Dil-
labeled MSCs expressed sarcomeric-α-actinin as measured by flow cytometry. Immuno-
cytochemistry showed that only these MSCs expressed the cardiac markers. MSCs
transdifferentiation was not observed with other coculture condition as well as condi-
tioned medium. Calcein-AM labeling of cardiomyocytes showed gap junctional communi-
cation between 56.1 ± 2.0 % of MSCs (24 hours after labeling, n=5) and neonatal
cardiomyocytes. When MSCs cocultured with paraformaldehyde-fixed neonatal cardi-
omyocytes, they also expressed sarcomeric-α-actinin. EDTA abolished the adhesion of
MSCs to fixed neonatal cardiomyocytes. Conclusions: These findings suggest that
MSCs are capable of differentiating into cardiomyocytes when directly cocultured with
neonatal cardiomyocytes by cell-to-cell interaction, but not with adult cardiomyocytes or
with conditioned medium. This finding provides the model to study the mechanism to dif-
ferentiate MSCs into cardiomyocytes by microenvrionment.
1078-92 Human Umbilical Cord Mononuclear Cells Limit Acute 
Myocardial Infarction Size
Robert J. Henning, Hamdi Abu-Ali, John Randolph, Michael Morgan, John Balis, Alison 
Willing, Paul Sanberg, University of South Florida, Tampa, FL, James A. Haley VA 
Hospital, Tampa, FL
Background: We hypothesized that Human Umbilical Cord mononuclear Blood Cells
(HUCBC) can limit acute myocardial infarction size and improve cardiac function.
Methods: Infarction was produced in rats by either left anterior descending coronary
artery permanent occlusion (n=35) or occlusion for one hour then reperfusion (n=36).
Rats from each study were combined because of similar findings. Group 1 consisted of
24 control rats with no intervention. In Group 2 (n=33) the hearts were infarcted but no
HUCBC injected. In Group 3 (n=38) one million HUCBC were injected at the ischemic
zone edges 1 hour after coronary ligation. Immunosuppression was not given to any rat.
Echocardiography was performed at baseline and at 1, 2, 3 and 4 months of observation.
